* Veracyte Inc VCYT.OQ reported a quarterly adjusted loss
of 11
cents per share for the quarter ended in March. The mean
expectation of nine analysts for the quarter was for a loss
of 13 cents per share.
* Revenue rose 21.6% to $82.42 million from a year ago;
analysts
expected $75.81 million.
* Veracyte Inc's reported EPS for the quarter was a loss
of 11
cents.
* The mean earnings estimate of analysts had risen by
about 10.8%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
* Veracyte Inc shares had fallen by 3.5% this quarter and
lost 9.3% so far this year.
* The company reported a quarterly loss of $8.09 million.
* Wall Street's median 12-month price target for Veracyte
Inc is
$34.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
4 at 09:48 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.13 -0.11 Beat
Dec. 31 2022 -0.15 -0.05 Beat
Sep. 30 2022 -0.25 -0.12 Beat
Jun. 30 2022 -0.22 -0.13 Beat